New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AHS;CMCSA;GRPN;MOH;NNA;PM;PL;UTIW;WU;PRO;IRWD;ZMH;MDU;BPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
October 21, 2014
17:25 EDTGRPNGroupon initiated with a Buy at Brean Capital
Subscribe for More Information
06:30 EDTPMPhilip Morris implied volatility of 15 at lower end of index mean range
October 20, 2014
16:14 EDTGRPNGroupon updates IPhone app to include Apple Pay
Subscribe for More Information
08:08 EDTIRWDIronwood presents IW-9179 Phase IIa clinical study data
Subscribe for More Information
October 17, 2014
09:59 EDTCMCSAComcast volatility elevated into Q3 and outlook
Subscribe for More Information
09:29 EDTCMCSAComcast it top large cap pick into the print, says Goldman
Goldman said Comcast is its top large cap pick into the earnings report given steady fundamentals, moderated expectations, and valuation. Shares are Buy rated with a $64 price target.
08:00 EDTCMCSAHBO may have fight with cable operators over OTT service price, Reuters says
Subscribe for More Information
October 16, 2014
15:10 EDTIRWDAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
08:02 EDTIRWDIronwood announces initiation of Phase II linaclotide trial
Ironwood Pharmaceuticals (IRWD) announced the initiation of a Phase II clinical trial evaluating linaclotide for the treatment of adults suffering from opioid-induced constipation. Data are expected in the second half of 2015. The clinical trial is being conducted jointly by Ironwood and Actavis plc (ACT), Ironwood’s co-development and co-promotion partner for linaclotide in the United States. Linaclotide is a guanylate cyclase-C agonist approved by the FDA for the treatment of adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Linaclotide is not currently approved for the treatment of OIC. The randomized, double-blind, placebo-controlled, multi-site Phase II clinical trial is expected to enroll approximately 240 adult patients with chronic, non-cancer pain who have been receiving a stable dose of an opioid analgesic and suffer from constipation, defined as fewer than three spontaneous bowel movements per week. Patients will be randomized to receive 145 mcg of linaclotide, 290 mcg of linaclotide, or placebo for eight weeks. The primary endpoint of the trial is an increase in SBM frequency. Additionally, a number of secondary endpoints and exploratory analyses intended to inform future development plans are included in the study design.
07:07 EDTPMPhilip Morris narrows 2014 adjusted EPS growth outlook to 6.5%-7.5%
Subscribe for More Information
07:04 EDTPMPhilip Morris reports adjusted Q3 EPS $1.39, consensus $1.33
Subscribe for More Information
October 15, 2014
16:00 EDTCMCSAOptions Update; October 15, 2014
Subscribe for More Information
15:28 EDTPMNotable companies reporting before tomorrow's open
Subscribe for More Information
07:27 EDTMOHModern Healthcare to hold a virtual conference
Building Tomorrow's Delivery Model: Forging a Path to Value is being held on October 15 at 9:30 am. Webcast Link
October 14, 2014
16:08 EDTMDUAvista 'quietly' seeks buyer, Berkshire interested, TheDeal.com says
Subscribe for More Information
14:01 EDTPMPhilip Morris October volatility elevated into Q3 and guidance
Subscribe for More Information
12:33 EDTZMHZimmer, Stryker have postive read-through from J&J, says Wells Fargo
Subscribe for More Information
11:11 EDTZMHJohnson & Johnson Ortho strength positive for Zimmer, says Piper Jaffray
Piper Jaffray said Johnson & Johnson's (JNJ) sequential Q3 strength in orthopedics, which included acceleration in both hips and knees, was surprising and a positive for Zimmer (ZMH). However, Piper expect sentiments on ortho names to remain muted until further into reporting season, noting that Stryker (SYK) is scheduled to report Thursday after the close. The firm has Neutral rating on Johnson & Johnson and Stryker and an Overweight rating on Zimmer.
October 13, 2014
06:32 EDTCMCSAUniversal receives approval to open $3.27B theme park in Beijing, WSJ reports
Subscribe for More Information
October 12, 2014
15:54 EDTCMCSA21st Century Fox's 'Gone Girl' wins at box office with $26.8M, Bloomberg says
21st Century Fox's (FOX, FOXA) “Gone Girl” took first place at the box office this weekend taking in $26.8M, says Bloomberg. "Dracula Untold,” from Comcast's (CMCSA) Universal Pictures came in second this weekend taking in $23.5M, added Bloomberg. Reference Link
October 10, 2014
13:17 EDTCMCSANielsen to restate some TV rating due to software glitch, Variety reports
Nielsen (NLSN) acknowledged it uncovered a software error on October 6 that had resulted in TV ratings being allocated incorrectly among broadcast and syndication programming since March 2 and that it would restate the ratings accordingly to fix the errors, reported Variety. The company said 98% to 99% of ratings would not be affected by more than .05 of a ratings point and a person familiar with the situation said some TV networks have an expectation that some of their new fall programming will see a very slight uplift due to the restatement, the report noted. The big four broadcast networks are operated by CBS (CBS), Comcast (CMCSA), Disney (DIS) and 21st Century Fox (FOXA). Reference Link
10:01 EDTGRPNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTGRPNOn The Fly: Pre-market Movers
Subscribe for More Information
08:13 EDTGRPNGroupon downgraded to Sell from Equal Weight at Evercore
07:04 EDTCMCSAAmazon in talks to join digital locker for movies. WSJ reports
Subscribe for More Information
06:48 EDTPMSenators call on FDA to adopt strict e-cigarette warning
Subscribe for More Information
October 9, 2014
11:00 EDTCMCSATime Warner Cable stockholders approve Comcast merger deal
Subscribe for More Information
10:59 EDTCMCSATime Warner Cable stockholders approve Comcast merger deal
Subscribe for More Information
08:18 EDTCMCSATime Warner Cable to host special shareholder meeting
Subscribe for More Information
08:04 EDTWUWestern Union continues expansion, signs Mi Pueblo
Subscribe for More Information
06:18 EDTZMHBiomet reports Q1 sales up 6% to $775M
Subscribe for More Information
October 8, 2014
11:04 EDTCMCSAComcast shareholders approve stock issuance for Time Warner Cable merger
Subscribe for More Information
11:03 EDTCMCSAComcast shareholders approve stock issuance for Time Warner Cable merger
Subscribe for More Information
07:13 EDTCMCSAHulu may cut number ads on Hulu Plus, NY Post reports
Hulu (FOXA, DIS, CMCSA) CEO Mike Hopkins is looking to cut back on the number of ads that appear on Hulu Plus, reports the New York Post. According to an executive close to the company, Hulu and its partners are “always looking at a variety of ways to create the best possible experience for our viewers and advertisers including reducing the ad load." Reference Link
October 7, 2014
10:02 EDTNNAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:50 EDTNNANavios Acquisition initiated with a Buy at GMP Securities
Target $4.50.
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use